{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T23:01:30Z","timestamp":1781478090892,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3841,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1111\/j.1523-1755.2005.09504.x","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T13:58:47Z","timestamp":1115387927000},"page":"S28-S32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"S95","title":["The role of daily dialysis in the control of hyperphosphatemia"],"prefix":"10.1016","volume":"67","author":[{"given":"Steven G.","family":"Achinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Ayus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1111\/j.1523-1755.2005.09504.x_bb0010","first-page":"S87","article-title":"Causes of death","volume":"34","author":"US Renal Data Systems","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and serum calcium \u00d7 phosophate with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0020","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","article-title":"Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to folate and pyridoxine concentrations","volume":"94","author":"Robinson","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-reactive protein predicts all-cause mortality and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"Suppl","key":"10.1111\/j.1523-1755.2005.09504.x_bb0030","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1046\/j.1523-1755.61.s80.18.x","article-title":"Inflammation and cardiovascular risk in dialysis patients","volume":"61","author":"Wanner","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","article-title":"End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?","volume":"59","author":"Arici","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0040","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmerman","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0045","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ndt\/11.7.1277","article-title":"Outcome and risk factors for left ventricular disorders in chronic uraemia","volume":"11","author":"Parfrey","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0050","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","article-title":"Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function and bone in rats with renal failure","volume":"66","author":"Neves","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in hemodialysis patients. The predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"35","author":"Lowrie","year":"1990","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 22","key":"10.1111\/j.1523-1755.2005.09504.x_bb0060","first-page":"S215","article-title":"Prevention of phosphate retention and hyperphosphatemia in uremia","volume":"32","author":"Hercz","year":"1987","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(12)80882-1","article-title":"Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate","volume":"18","author":"Hou","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/039139888701000308","article-title":"Inorganic phosphate removal during different dialytic procedures","volume":"10","author":"Zucchelli","year":"1987","journal-title":"Int J Artif Organs"},{"issue":"Suppl 2","key":"10.1111\/j.1523-1755.2005.09504.x_bb0075","first-page":"114","article-title":"Phosphate removal rate: A comparative study of five high-flux dialysers","volume":"6","author":"Chauveau","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0080","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1681\/ASN.V451214","article-title":"Phosphate kinetics during high-flux hemodialysis","volume":"4","author":"Desoi","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0085","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.V1341046","article-title":"Postdialytic rebound of serum phophorus: pathogenetic and clinical insights","volume":"13","author":"Minutolo","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0090","first-page":"461","article-title":"Phosphorus kinetics during haemodialysis and haemofiltration","volume":"21","author":"Pogglitsch","year":"1984","journal-title":"Proc EDTA-ERA"},{"issue":"Suppl 1","key":"10.1111\/j.1523-1755.2005.09504.x_bb0095","first-page":"S57","article-title":"Phosphate removal during dialysis: Does the membrane matter?","volume":"42","author":"Ritz","year":"1994","journal-title":"Clin Nephrol"},{"issue":"Suppl 2","key":"10.1111\/j.1523-1755.2005.09504.x_bb0100","first-page":"108","article-title":"Phosphate kinetics in dialysis patients","volume":"6","author":"Haas","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00041552-200307000-00005","article-title":"Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients","volume":"12","author":"Nolan","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.0894-0959.2004.17308.x","article-title":"The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease","volume":"17","author":"Goodman","year":"2004","journal-title":"Semin Dial"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0115","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","article-title":"Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure","volume":"29","author":"Chertow","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0125","series-title":"Kidney Int (Suppl 90)","first-page":"S39","article-title":"Acid loading during treatment with sevelamer hydrochloride: Mechanisms and clinical implications","author":"Brezina","year":"2004"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0130","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMoa021583","article-title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis","volume":"34","author":"Eknoyan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0135","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajkd.2003.07.020","article-title":"Long-term study of high comorbidity ESRD patients converted from conventional to short daily hemodialysis","volume":"42","author":"Ting","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000057427","article-title":"Left ventricular hypertrophy in daily dialysis","volume":"25","author":"Buoncristiani","year":"1999","journal-title":"Miner Electrolyte Metab"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/ajkd.2001.26103","article-title":"Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients","volume":"38","author":"Fagugli","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ndt\/gfh550","article-title":"Dialysis dose and frequency","volume":"20","author":"Locatelli","year":"2005","journal-title":"Nephol Dial Transpant"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00002480-200201000-00012","article-title":"Reduced requirement for erythropoietin with quotidian hemodialysis therapy","volume":"48","author":"Klarenbach","year":"2002","journal-title":"ASAIOJ"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1073-4449(96)80053-7","article-title":"Slow nocturnal home hemodialysis at the Wellesley Hospital","volume":"3","author":"Uldall","year":"1996","journal-title":"Adv Ren Replace Ther"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0165","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1093\/ndt\/13.11.2853","article-title":"Daily home haemodialysis in The Netherlands: Effects on metabolic control, haemodynamics, and quality of life","volume":"13","author":"Kooistra","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0170","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1523-1755.1998.00875.x","article-title":"Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis","volume":"53","author":"Mucsi","year":"1998","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1111\/j.1523-1755.2005.09504.x_bb0175","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0272-6386(03)00534-1","article-title":"Calcium and phosphate balance with quotidian dialysis","volume":"42","author":"Lindsay","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.09504.x_bb0180","first-page":"736A","article-title":"Control of severe hyperparathyroidism (SHP) by short daily dialysis (SDHD) with concomitant use of high dose vitamin D analogue (paricalcitol)","volume":"15","author":"Mizani","year":"2004","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815508041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815508041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:45:16Z","timestamp":1758761116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815508041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":35,"alternative-id":["S0085253815508041"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.09504.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of daily dialysis in the control of hyperphosphatemia","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.09504.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}